The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression

Katharina Dannehl,1 Winfried Rief,1 Markus J Schwarz,2 Annika Hennings,1 Sabine Riemer,1 Verena Selberdinger,3 Theresa Stapf,3 Frank Euteneuer11Division of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany; 2Institute for Laboratory Medicine, Ludwig-Maxi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dannehl K, Rief W, Schwarz MJ, Hennings A, Riemer S, Selberdinger V, Stapf T, Euteneuer F
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/61ad742b67f048d5bd65a00451a51843
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:61ad742b67f048d5bd65a00451a51843
record_format dspace
spelling oai:doaj.org-article:61ad742b67f048d5bd65a00451a518432021-12-02T05:36:39ZThe predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression1178-2021https://doaj.org/article/61ad742b67f048d5bd65a00451a518432014-06-01T00:00:00Zhttp://www.dovepress.com/the-predictive-value-of-somatic-and-cognitive-depressive-symptoms-for--a17406https://doaj.org/toc/1178-2021 Katharina Dannehl,1 Winfried Rief,1 Markus J Schwarz,2 Annika Hennings,1 Sabine Riemer,1 Verena Selberdinger,3 Theresa Stapf,3 Frank Euteneuer11Division of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany; 2Institute for Laboratory Medicine, Ludwig-Maximilian Universität, Munich, Germany; 3Department of Psychiatry, Ludwig-Maximilian Universität, Munich, GermanyContext: Elevated concentrations of proinflammatory cytokines have been hypothesized as an important factor in the pathophysiology of depression. Depression itself is considered to be a heterogeneous disorder. Current findings suggest that “cognitive” and “somatic” symptom dimensions are related to immune function in different ways. So far, little research has been done on the longitudinal aspects of inflammation in patients with major depression, especially with respect to different symptom dimensions of depression. Therefore, we investigated which aspects of depression may predict changes in tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 over 4 weeks. Methods: Forty-one patients with major depression diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and 45 healthy controls were enrolled. Serum measurements of TNF-alpha and IL-6 were conducted at baseline and 4 weeks later. Psychometric measures included the assessment of cognitive-affective depressive symptoms and somatic symptoms during the last 7 days as well as somatic symptoms during the last 2 years. Results: Patients with depression showed increased levels of TNF-alpha (P<0.05) compared to healthy controls. Hierarchical regression analyses indicated that neither depressive nor somatic symptoms predict changes in proinflammatory cytokines in the whole sample of depressed patients. Moderation analyses and subsequent sex-stratified regression analyses indicated that higher somatoform symptoms during the last 2 years significantly predict an increase in TNF-alpha in women with major depression (P<0.05) but not in men. Exploratory ­analyses ­indicated that the stability of TNF-alpha and IL-6 (as indicated by intraclass correlation ­coefficients) over 4 weeks was high for TNF-alpha but lower for IL-6.Conclusion: The present study demonstrated that a history of somatoform symptoms may be important for predicting future changes in TNF-alpha in women with major depression. Keywords: interleukin-6, tumor necrosis factor-alpha, symptom dimensionDannehl KRief WSchwarz MJHennings ARiemer SSelberdinger VStapf TEuteneuer FDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 1191-1197 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Dannehl K
Rief W
Schwarz MJ
Hennings A
Riemer S
Selberdinger V
Stapf T
Euteneuer F
The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
description Katharina Dannehl,1 Winfried Rief,1 Markus J Schwarz,2 Annika Hennings,1 Sabine Riemer,1 Verena Selberdinger,3 Theresa Stapf,3 Frank Euteneuer11Division of Clinical Psychology and Psychotherapy, Philipps Universität Marburg, Marburg, Germany; 2Institute for Laboratory Medicine, Ludwig-Maximilian Universität, Munich, Germany; 3Department of Psychiatry, Ludwig-Maximilian Universität, Munich, GermanyContext: Elevated concentrations of proinflammatory cytokines have been hypothesized as an important factor in the pathophysiology of depression. Depression itself is considered to be a heterogeneous disorder. Current findings suggest that “cognitive” and “somatic” symptom dimensions are related to immune function in different ways. So far, little research has been done on the longitudinal aspects of inflammation in patients with major depression, especially with respect to different symptom dimensions of depression. Therefore, we investigated which aspects of depression may predict changes in tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 over 4 weeks. Methods: Forty-one patients with major depression diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and 45 healthy controls were enrolled. Serum measurements of TNF-alpha and IL-6 were conducted at baseline and 4 weeks later. Psychometric measures included the assessment of cognitive-affective depressive symptoms and somatic symptoms during the last 7 days as well as somatic symptoms during the last 2 years. Results: Patients with depression showed increased levels of TNF-alpha (P<0.05) compared to healthy controls. Hierarchical regression analyses indicated that neither depressive nor somatic symptoms predict changes in proinflammatory cytokines in the whole sample of depressed patients. Moderation analyses and subsequent sex-stratified regression analyses indicated that higher somatoform symptoms during the last 2 years significantly predict an increase in TNF-alpha in women with major depression (P<0.05) but not in men. Exploratory ­analyses ­indicated that the stability of TNF-alpha and IL-6 (as indicated by intraclass correlation ­coefficients) over 4 weeks was high for TNF-alpha but lower for IL-6.Conclusion: The present study demonstrated that a history of somatoform symptoms may be important for predicting future changes in TNF-alpha in women with major depression. Keywords: interleukin-6, tumor necrosis factor-alpha, symptom dimension
format article
author Dannehl K
Rief W
Schwarz MJ
Hennings A
Riemer S
Selberdinger V
Stapf T
Euteneuer F
author_facet Dannehl K
Rief W
Schwarz MJ
Hennings A
Riemer S
Selberdinger V
Stapf T
Euteneuer F
author_sort Dannehl K
title The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
title_short The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
title_full The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
title_fullStr The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
title_full_unstemmed The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
title_sort predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/61ad742b67f048d5bd65a00451a51843
work_keys_str_mv AT dannehlk thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT riefw thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT schwarzmj thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT henningsa thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT riemers thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT selberdingerv thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT stapft thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT euteneuerf thepredictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT dannehlk predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT riefw predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT schwarzmj predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT henningsa predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT riemers predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT selberdingerv predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT stapft predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
AT euteneuerf predictivevalueofsomaticandcognitivedepressivesymptomsforcytokinechangesinpatientswithmajordepression
_version_ 1718400300363022336